Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
5,169 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
16,120 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
528 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
1,633 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
10,117 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
31,463 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
626 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
1,942 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
16,440 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
51,158 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
16,440 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
51,158 |
CARE_NEW |
Aggregated Age/sex: <15 Female |
2016 |
118 |
CARE_NEW |
Aggregated Age/sex: <15 Male |
2016 |
104 |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2016 |
1,990 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2016 |
1,063 |
CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
3,275 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2016 |
3,275 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2016 |
3,275 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2016 |
31 |
PMTCT_EID |
By infants who received a virologic test within 2 months of birth |
2016 |
3,835 |
PMTCT_EID |
By infants who received their first virologic HIV test between 2 and 12 months of age |
2016 |
420 |
PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2016 |
4,257 |
PMTCT_EID |
Sum of Infant Age disaggregates |
2016 |
4,255 |
TB_ART |
Aggregated Age: <15 |
2016 |
62 |
TB_ART |
Aggregated Age: 15+ |
2016 |
755 |
TB_ART |
Female |
2016 |
525 |
TB_ART |
Male |
2016 |
292 |
TB_ART |
Sum of Aggregated Age disaggregates |
2016 |
817 |
TB_ART |
Sum of Sex disaggregates |
2016 |
817 |
TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period |
2016 |
817 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 |
2016 |
3,586 |
TB_SCREEN |
Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ |
2016 |
47,661 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
16,440 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
51,158 |
TB_SCREEN |
Sex: Female |
2016 |
33,471 |
TB_SCREEN |
Sex: Male |
2016 |
17,776 |
TB_SCREEN |
Sum of Aggregated Age disaggregates |
2016 |
51,247 |
TB_SCREEN |
Sum of Sex disaggregates |
2016 |
51,247 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2016 |
51,247 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
4,487 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
13,983 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
9,884 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
30,259 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
15,515 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
14,371 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
44,242 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
14,371 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
44,242 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2016 |
2,576 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2016 |
5,450 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2016 |
8,374 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2016 |
8,026 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2016 |
11,929 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2016 |
14,022 |
VMMC_AE |
Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) |
2016 |
72 |
VMMC_CIRC |
By circumcision technique: Device-based VMMC |
2016 |
2,133 |
VMMC_CIRC |
By circumcision technique: Surgical VMMC |
2016 |
19,168 |
VMMC_CIRC |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2016 |
21,296 |
VMMC_CIRC |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2016 |
4,687 |
VMMC_CIRC |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2016 |
16,228 |
VMMC_CIRC |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2016 |
384 |
VMMC_CIRC |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2016 |
21,296 |